← Back to patent-cliff list
LPCN-1148
Tier C — Watch / tradeLPCN-1148
Lipocine Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：AR
Indications (approved)：Liver cirrhosis, 肌肉减少症
Regional status
US
Phase II
2021-11-30
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of LPCN-1148?
Approved indications include: Liver cirrhosis, 肌肉减少症.
When does the LPCN-1148 patent expire?
No public expiry year is available for LPCN-1148 yet; this page updates once verified.
How do I get a quote for LPCN-1148 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21